Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-006089-32Phase 4Completed
Phase 4, randomised trial of chlorhexidine + neomycin in epistaxis (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Proportion of children with no nose bleeds in the 4 weeks prior to clinical review. Started Mar 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-006089-32.